This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the use of spatial and molecular profiling systems from NanoString, 10x Genomics, and Akoya Biosciences

Ticker(s): TGX, NSTG, AKYA

Who's the expert?

Institution: Wellcome Sanger Institute

  • Neuroscientist at Wellcome Sanger Institute, United Kingdom who leads the Sanger-EBI High-Throughput Spatial Genomics Team to develop experimental and computational platforms to map human tissue architecture at scale.
  • Research focus on harnessing spatial transcriptomics, imaging and functional screening to study neural diversity in health and disease.
  • His group has developed new computational tools to integrate single cell and spatial transcriptomics data for comprehensive mapping of cell types across complex tissues.

Interview Questions
Q1.

Describe your background and research setting

Added By: ben_admin
Q2.

Which spatial profiling systems have you used to date?

Added By: ben_admin
Q3.

What are some of the differences between systems?

Added By: ben_admin
Q4.

How much bigger of an opportunity is Xenium than Visium? Over the next 5 years?

Added By: decameron capital

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.